Dynamics of long-term statin therapy

European Journal of Clinical Pharmacology

Volumn 67, Issue 9, 2011, Pages 925-931

  Korhonen, Maarit Jaana ^a,b   Helin Salmivaara, Arja ^a,c   Huupponen, Risto ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adherence; Claims data; Drug use pattern; Misclassification

Indexed keywords

ATORVASTATIN; EZETIMIBE PLUS SIMVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG MONITORING; DRUG USE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FINLAND; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; FINLAND; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSURANCE, HEALTH, REIMBURSEMENT; KINETICS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TIME FACTORS;

EID: 80054786168     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1019-2     Document Type: Article

References (30)

1. Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 366:1267-1278
2. Brugts JJ, Yetgin T, Hoeks SE et al (2009) The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomised controlled trials. Br Med J 338:b2376
3. Shalev V, Chodick G, Silber H et al (2009) Continuation of statin treatment and all-cause mortality. Arch Intern Med 169:260-268
4. Perreault S, Dragomir A, Blais L et al (2009) Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol 65:1013-1024
5. Corrao G, Conti V, Merlino L et al (2010) Results of retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily practice in Italy. Clin Ther 32:300-310
6. Benner JS, Glyn RJ, Mogun H et al (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA 288:455-461 (Pubitemid 34787476)
7. Mantel-Teeuwisse AK, Goettsh WG, Klungel OH et al (2004) Long term persistence with statin treatment in daily medical practice. Heart 90:1056-1066
8. Perreault S, Blais L, Lamarre D et al (2005) Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol 59:564-573 (Pubitemid 40632247)
9. Helin-Salmivaara A, Lavikainen P, Korhonen MJ et al (2008) Long-term persistence with statin therapy: A nation-wide register study. Clin Ther 30(pt 2):2228-2240
10. Helin-Salmivaara A, Lavikainen P, Korhonen MJ et al (2010) Pattern of statin use among 10 cohorts of new users from 1995 to 2004: A register-based nationwide study. Am J Manag Care 16:116-122
11. Risselada R, Straatman H, van Kooten F et al (2009) Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke 40:2887-2892
12. Daskapoulou SS, Delaney JA, Fillion KB et al (2008) Discontinuation of statin therapy following an acute myocardial infarction: A population-based study. Eur Heart J 79:2083-2091
13. Pineda A, Cubeddu LX (2010) Statin rebound or withdrawal syndrome: Does it exist? Curr Athreoscler Rep 13:23-30
14. Hudson M, Rahme E, Richard H et al (2007) Comparison of measures of medication persistency using a prescription drug database. Am Heart J 153:59-65 (Pubitemid 44880894)
15. Brookhart MA, Patrick AR, Schneeweiss S et al (2007) Physician follow-up and provider continuity are associated with long-term medication adherence. Arch Intern Med 167:847-852 (Pubitemid 46658345)
16. Ray WA (2003) Evaluating medication effects outside clinical trials: New-user designs. Am J Epidemiol 158:915-920 (Pubitemid 37323253)
17. Scranton RE, Young M, Lawler E et al (2005) Statin use and fracture risk. Arch Intern Med 165:2007-2012
18. Willke RJ, Zhou S, Vogel RA (2008) Differences in cardiovascular event rates between atorvastatin and simvastatin among new users: Managed-care experience. Curr Med Res Opin 24:2873-2882
19. Smeeth L, Douglas I, Hall AJ et al (2008) Effect of statins on a wide range of health outcomes: A cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 67:99-109
20. Chodick G, Heymann AD, Flash S et al (2010) Persistence with statins and incident cataract: A population-based historical cohort study. Ann Epidemiol 20:136-142
21. Furu K, Wettermark B, Andersen M et al (2009) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106:86-94
22. Peura S, Raijaniemi S, Kurkijärvi U. Pharmaceutical Pricing and Reimbursement Information Project. Finland 2007. Available at: Http://ppri.oebig.at/Downloads/Results/Finland-PPRI-2007.pdf. Accessed 1 Feb, 2010
23. Martikainen JE, Saastamoinen LK, Korhonen MJ et al (2010) Impact of restricted reimbursement on the use of statins in Finland. A register-based study. Med Care 48:761-766
24. World Health Organization (WHO). About the ATC/DDD system. Available at: Http://www.whocc.no/atcddd/Accessed 1 Feb, 2010
25. Andrade SE, Kahler KH, Frech F et al (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565-574 (Pubitemid 44336271)
26. Simpson S, Eurich D, Majumdar S et al (2006) A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J 333(7557):15
27. Hippisley-Cox J, Coupland C (2010) Unintended effects of statins in men and women in England and Wales: Population based cohort study using the QResearch database. Br Med J 340:c2197. doi:10.1136/bmj.c2197
28. Schneeweiss S, Patrick AR, Maclure M et al (2007) Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: A population-based natural experiment. Circulation 115:2128-2135 (Pubitemid 46659064)
29. Dormuth C, Scneeweiss S, Brookhart A et al (2007) Factors related to splitting tablets of HMG-CoA reductase inhibitors: A population based analysis in British Columbia. Pharmacoepidemiol Drug Saf 16:5137
30. Steiner JF (2010) Can we identify clinical predictors of medication adherence⋯.and should we? Med Care 48:193-195